Tom-Castro XM, Rodriguez-Arrastia M, Cardona D, Rueda-Ruzafa L, Molina-Torres G, Roman P
This finding was consistent across baseline BMI subgroups, indicating direct cardiorenal effects of semaglutide independent of weight loss
DT received funding for educational sessions from: Novo Nordisk, Eli Lilly, Boehringer-Ingelheim, Guidotti, Astra Zeneca, Sanofi and Bruno Farmaceutici
Louis, MO)
These considerations are especially important, as CMS has opted not to require coverage for obesity treatments in Medicare for 2026, leaving commercial payers to independently navigate the issue
This system uses selective digestion of sample DNA with methylation-sensitive and methylation-dependent restriction enzymes, followed by quantification of the remaining DNA using real-time PCR